News
Hosted on MSN1m
Pfizer shares rise 3% after upping profit forecast for 2025Pfizer is one of many companies undergoing cost-saving strategies. The company said it is on track to deliver $7.2bn in net ...
The Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed ...
Health and Human Services Secretary Robert F. Kennedy Jr. has canceled $500 million in vaccine development after “listening ...
CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...
Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...
Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...
Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...
Moderna faces weak post-pandemic vaccine demand and financial struggles, with limited near-term catalysts. Click here to read ...
A U.K. Court of Appeals ruling confirms the validity of a patent covering modifications of mRNA used in Moderna’s vaccines.
3d
The Manila Times on MSNPfizer and BioNTech lose UK court appeal over Covid-19 jabPfizer says it will appeal the Aug 1 ruling to Britain’s Supreme Court. Read more at straitstimes.com. Read more at ...
London's Court of Appeal on Friday struck down a case filed by Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX), in a bid to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results